RF
Robert B Ford
Chairman and CEO

Robert B Ford insider trades: Abbott Laboratories (ABT) stock buys and sales

Chairman and CEO, Abbott Laboratories Last trade Aug 25, 2026 48 Form 4 filings
$46.2M
Sold, last 12 months
1 sale
$2.0M
Bought, last 12 months
1 buy
9
Open-market trades
since 2016
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 25, 2026ABT↓ Sell$46.2M
Jan 23, 2026ABT↑ Buy$2.0M
Feb 5, 2025ABT↓ Sell$37.4M
Sep 12, 2024ABT↓ Sell$16.5M
Aug 25, 2022ABT↓ Sell$10.8M
Jan 30, 2018ABT↓ Sell$2.7M
Jan 30, 2018ABT↓ Sell$2.6M
Dec 14, 2016ABT↑ Buy$499K
Feb 29, 2016ABT↓ Sell$67K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABT insiders

Open-market trades in the last 12 months

About Robert B Ford's insider trades

Robert B Ford is Chairman and CEO at Abbott Laboratories (ABT). Since Feb 29, 2016, Robert has reported 2 open-market purchases worth $2.5M and 7 sales worth $116.2M on SEC Form 4. In the last 12 months: 1 buy ($2.0M) and 1 sale ($46.2M).

Their filings also include shares withheld for taxes (17 filings), grants and awards (15 filings), gifts (10 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.